NEW YORK, March 12, 2020 /PRNewswire/ -- Today, March 12, is World Kidney Day, and the National Kidney Foundation (NKF) would like you to observe the occasion by dedicating one minute of your day to take the

BOZEMAN, Mont., March 12, 2020 /PRNewswire/ -- The healthcare communication platform company, Pulsara, announced today that they are expanding their Pulsara ONE package, and that it will now be offered at no cost to all referring facilities. Effective immediately, Pulsara ONE enables live streaming video, consult, and transfer capabilities for any referring faciliti

PLYMOUTH MEETING, Pa., March 12, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a

CEDAR KNOLLS, N.J., March 12, 2020 /PRNewswire/ --MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle in humans and canines, announced today that it has signed a distribut

WASHINGTON, March 12, 2020 /PRNewswire/ -- United Chinese Americans (UCA), a national coalition of Chinese Americans in more than 30 states, calls on the American news media, public figures and the American public to refrain from using terms such as "China virus," "Chinese virus," "Wuhan virus," or "Asian

LEXINGTON, Mass., March 12, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its fourth quarter and full-year 2019 financial results on Thursday, March 19, 2020, after the close of US m

SAN DIEGO, March 12, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ:EVFM), a clinical-stage biopharmaceutical company, today reported financial results for the three- and twelve- month periods ended December 31, 2019.

SAN DIEGO, March 12, 2020 /PRNewswire/ -- Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced it has successfully discovered a novel genetic biomarker associated with DB104 response to treat depression using its proprietary biomarker discovery platform. DB104 was licensed from Albany Molecular Research

SAN DIEGO, March 12, 2020 /PRNewswire/ -- IQ4I Research & Consultancy published a new report on "Cerebral and Pulse Oximeter Global Market – Forecast To 2026" 

RIDGEFIELD, Conn. and INDIANAPOLIS, March 12, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of Jardiance® (empagliflozin) to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease, Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) a